A preclinical study by biomedical scientists at the University of California, Riverside, has shown why some people with ...

Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

Seizures in people with MS may be driven by changes in levels of certain brain signaling molecules, according to a mouse ...

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These ...

About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting more than 2.9 million people worldwide. It occurs when the ...

Researchers have identified two compounds capable of repairing the protective myelin sheath damaged by multiple sclerosis, a major advance toward reversing nerve injury rather than just slowing it.

Researchers have identified two forms of estrogen, estradiol and estriol, that may reduce inflammation and protect nerve fibers in progressive multiple sclerosis (MS).

Despite being one of the most common and well-known neurodegenerative diseases, multiple sclerosis (MS) remains difficult to treat. However, new research from scientists at Cincinnati Children’s ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may ...

An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears ...

With over 1 million Americans affected by multiple sclerosis (MS), we wanted to learn more about its symptoms, particularly ...